Skip to main content
Contact Us
Subscribe
E-Edition
66°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Champions Oncolog
(NQ:
CSBR
)
5.060
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
82
Open
5.060
Bid (Size)
5.030 (4)
Ask (Size)
5.380 (2)
Prev. Close
5.060
Today's Range
5.060 - 5.060
52wk Range
4.170 - 7.320
Shares Outstanding
13,415,066
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Champions Oncology: Q3 Earnings Insights
March 12, 2024
Via
Benzinga
Champions Oncology Reports Quarterly Revenue of $12.0 Million
March 12, 2024
Via
ACCESSWIRE
Performance
YTD
-12.61%
-12.61%
1 Month
+0.80%
+0.80%
3 Month
-19.10%
-19.10%
6 Month
-16.64%
-16.64%
1 Year
+1.33%
+1.33%
More News
Read More
Earnings Scheduled For March 12, 2024
March 12, 2024
Via
Benzinga
Earnings Outlook For Champions Oncology
March 11, 2024
Via
Benzinga
Recap: Champions Oncology Q2 Earnings
December 12, 2023
Via
Benzinga
Earnings Outlook For Champions Oncology
September 12, 2023
Via
Benzinga
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
March 07, 2024
Via
ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
March 06, 2024
Via
ACCESSWIRE
Insiders Buying Solid Biosciences And 2 Other Stocks
January 16, 2024
Via
Benzinga
Insiders Buying Tilly's And 2 Other Stocks
January 10, 2024
Via
Benzinga
Why Is RiskOn International (ROI) Stock Up 28% Today?
December 13, 2023
Via
InvestorPlace
Champions Oncology Earnings Perspective: Return On Capital Employed
July 25, 2023
Via
Benzinga
Champions Oncology Reports Quarterly Revenue of $13.1 Million
July 24, 2023
Via
ACCESSWIRE
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
December 12, 2023
Via
InvestorPlace
Champions Oncology Reports Quarterly Revenue of $11.6 Million
December 12, 2023
Via
ACCESSWIRE
Earnings Scheduled For December 12, 2023
December 12, 2023
Via
Benzinga
Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
December 12, 2023
Via
Benzinga
Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day
December 12, 2023
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
December 04, 2023
Via
ACCESSWIRE
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
November 02, 2023
Via
ACCESSWIRE
Champions Oncology Announces the Addition of Brady Davis as President
October 17, 2023
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.6 Million
September 13, 2023
Via
ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
September 11, 2023
Via
ACCESSWIRE
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
August 22, 2023
Via
ACCESSWIRE
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
August 01, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.